SRTR Lung program · California · CASF

University of California San Francisco Medical Center

University of California San Francisco Medical Center's lung program in California (center code CASF). Survival figures are SRTR risk-adjusted estimates for a historical cohort, not a forecast for a named patient.

This data is for informational purposes only. It is not medical advice. Always consult your transplant team for decisions about your care.

Lung program picture · California

University of California San Francisco Medical Center's lung 1-year graft survival is 3.5 points above the national risk-adjusted benchmark.

83.9%
3-year graft survival
89.6%
National 1-yr benchmark
+3.5
Points vs national 1-yr
111
Waitlist additions (flow)

Survival estimates are SRTR risk-adjusted figures for a historical cohort. Waitlist stock and waitlist additions are separate inventory/flow fields, not a recommendation.

Lung program composite score

A
Composite Score
87/100
University of California San Francisco Medical Center · Lung

Based on this program's SRTR 1-year graft survival, 3-year graft survival, and transplant volume, each benchmarked against every other program reporting the same organ in the current cohort. Not a recommendation and not a forecast for any named patient.

1-Year Survival A-
93.2%
1-year graft survival vs every reporting lung program
3-Year Survival A+
83.9%
3-year graft survival vs every reporting lung program
Program Volume A
247
Transplants performed vs every reporting lung program

Waitlist stock vs additions

SRTR publishes waitlist size (stock) and waitlist additions (flow) as separate fields for the November 2025 Program-Specific Report window. Neither field is an individual wait-time estimate.

Stock (inventory)
21
Additions (flow)
111
Organ-class mean additions
54

This program: +57 vs mean among 64 ranked lung programs.

Other Lung Programs

Top-ranked peer programs by 1-year graft survival rate.

Frequently Asked Questions

What is the lung transplant survival rate at University of California San Francisco Medical Center?

According to SRTR data from November 2025, University of California San Francisco Medical Center reports a 1-year graft survival rate of 93.2% for lung transplants, compared to a national average of 89.6%. The 3-year survival rate is 83.9%. Survival rates are risk-adjusted estimates for a historical cohort, not a forecast for a named patient.

How many lung transplants does University of California San Francisco Medical Center report?

University of California San Francisco Medical Center reported 247 lung transplants in the current SRTR Program-Specific Report cohort. That count is inventory from the joined program row, not a quality grade.

How large is the lung waiting list at University of California San Francisco Medical Center?

SRTR reports approximately 21 candidates on this program's lung waiting list in the November 2025 cohort, with about 111 waitlist additions recorded in the same report window. Stock (inventory) and additions (flow) are different SRTR fields; this page does not estimate an individual's wait.

How many lung waitlist additions does University of California San Francisco Medical Center report?

SRTR records about 111 lung waitlist additions for University of California San Francisco Medical Center in the November 2025 Program-Specific Report window (organ-class mean among ranked programs: 54). Additions are cohort flow, not a predicted wait time or a recommendation.

How does University of California San Francisco Medical Center rank nationally for lung transplants?

University of California San Francisco Medical Center ranks #12 of 64 reporting lung programs by 1-year graft survival in this cohort. The center's rate is 3.5 percentage points above the national risk-adjusted benchmark. Rankings exclude programs below SRTR's published case-volume floor.

Which SRTR fields does this lung program publish?

This page reports the program's SRTR 1-year and 3-year graft survival estimates, transplants performed, waitlist stock, waitlist additions (flow), and the risk-adjusted national benchmark for lung. Rank order is among programs that meet SRTR's published case-volume floor. None of those fields is a recommendation to choose or avoid the center.

Data Sources

  • SRTR Program-Specific Reports (November 2025 release) - program-level survival rates, transplant volume, and waitlist size for University of California San Francisco Medical Center. srtr.org
  • OPTN lung allocation policy - organ-specific allocation rules referenced in this page's narrative. optn.transplant.hrsa.gov

About This Data

This data is for informational purposes only. It is not medical advice. Always consult your transplant team for decisions about your care.

Source: SRTR Program-Specific Reports, November 2025 Rankings exclude centers with insufficient case volume for statistical reporting

Every figure on PlainTransplant is rendered directly from SRTR Program-Specific Reports data, no number is typed in by an editor. Center×organ figures for University of California San Francisco Medical Center / Lung are computed directly from SRTR Program-Specific Reports; no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a correction. Data current as of November 2025.